Company Filing History:
Years Active: 2008-2010
Title: **Innovative Contributions of Steve Sezate in Retinal Cell Protection**
Introduction
Steve Sezate is an accomplished inventor based in Oklahoma City, OK, known for his significant contributions to the field of neuronal protection, particularly concerning retinal cells. With two patents to his name, Sezate's work focuses on innovative methods and compositions aimed at enhancing cellular resilience against harmful reactive oxygen species (ROS).
Latest Patents
Sezate's latest patents revolve around the inhibition of reactive oxygen species and the protection of mammalian cells. His research presents methods and compositions that are useful for neuronal protection in retinal cells, both in vitro and in vivo. Specifically, he introduces ultrafine nano-size cerium oxide particles, which are less than 10 nanometers in diameter. These particles play a crucial role in reducing reactive oxygen species in retinal tissue, which is pivotal in managing light-induced retinal degeneration and age-related macular degeneration (AMD). The innovative approach has shown promise in promoting the lifespan of retinal neurons and preventing apoptosis induced by hydrogen peroxide. By effectively decreasing the generation of intracellular ROS, cerium oxide particles are positioned as a vital asset in enhancing neuronal longevity in both in vitro and in vivo settings.
Career Highlights
Throughout his career, Steve Sezate has been associated with prestigious organizations such as the University of Central Florida Research Foundation and the University of Oklahoma. His dedication to research and innovation in the field of retinal health has garnered recognition and paved the way for advancements in treatment methodologies.
Collaborations
Collaboration has been a significant aspect of Sezate's work, with notable colleagues including James F. McGinnis and Junping Chen. These partnerships have enriched his research endeavors and contributed to the successful development of his patented innovations.
Conclusion
Steve Sezate's contributions to the field of retinal cell protection through his patents exemplify the vital role innovation plays in medical science. His work not only enhances our understanding of reactive oxygen species but also opens new avenues for therapeutic interventions in combating degenerative retinal diseases. As advancements in this area continue, Sezate's research stands as a beacon of hope for improving retinal health and promoting longevity in neuronal function.